obesity drug news today glp-1 2025 As drugs continue to gain popularity for weight loss, a lesser-known side effect is drawing attention from podiatrists: โOzempic feet.โ Story๐below ISPOR 2025: Exploring reasons for
Description
Circulation , 150 (19)
Biotech companies that are making the next generation of metabolic drugs can use this chemical in proof-of-concept studies that show how to use multiple targets
This pathway has been confirmed in multiple in vitro studies and in animal models
Androgenic alopecia follows a pattern, thinning at the crown and temples in men, diffuse thinning across the top of the scalp in women, and it does not resolve on its own the way telogen effluvium does
Ethics declarations Competing Interests Financial interests: Jaewang Lee and Hyun Jin Park are employed by Logsynk Ltd
